DAKAR, Aug 12 (Reuters) - Liberia will receive enough of an experimental Ebola drug to treat just two infected Liberian doctors, Information Minister Lewis Brown said, after the U.S. Food and Drug Administration (FDA) approved its export.
Brown said Liberia's Health Ministry had contacted the U.S. manufacturer of ZMapp, Mapp Biopharmaceutical, and asked the FDA to quickly approve its export.
The doctors had consented in writing to the treatment, the minister said. (Reporting by Daniel Flynn, editing by John Stonestreet)
Our Standards: The Thomson Reuters Trust Principles.
